Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in NASH
NCT00267670Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Mar 2005
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline in Nonalcoholic steatohepatitis (NASH), sponsored by Northwestern University. Started Mar 2005; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00267670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267670.